The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

Oct. 25, 2012
Applicant:

Corning Incorporated, Corning, NY (US);

Inventors:

Wendell Porter Weeks, Corning, NY (US);

Robert Anthony Schaut, Painted Post, NY (US);

Steven Edward DeMartino, Painted Post, NY (US);

John Stephen Peanasky, Big Flats, NY (US);

Assignee:

CORNING INCORPORATED, Corning, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61J 1/14 (2023.01); A61J 1/00 (2023.01); A61K 39/395 (2006.01); C03C 3/087 (2006.01); C03C 3/091 (2006.01); C03C 21/00 (2006.01); C03C 4/20 (2006.01); A61J 1/06 (2006.01); A61K 38/17 (2006.01); A61K 38/19 (2006.01); A61K 38/28 (2006.01); A61K 31/403 (2006.01); A61K 38/18 (2006.01); C07K 16/24 (2006.01);
U.S. Cl.
CPC ...
A61J 1/1468 (2015.05); A61J 1/00 (2013.01); A61J 1/065 (2013.01); A61K 31/403 (2013.01); A61K 38/17 (2013.01); A61K 38/1816 (2013.01); A61K 38/193 (2013.01); A61K 38/28 (2013.01); A61K 39/3955 (2013.01); C03C 3/087 (2013.01); C03C 3/091 (2013.01); C03C 4/20 (2013.01); C03C 21/002 (2013.01); C07K 16/241 (2013.01); Y02A 50/30 (2018.01); Y10T 428/131 (2015.01);
Abstract

The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, HUMALOG (insulin lispro), HUMALOG MIX 75-25 (insulin lispro), HUMALOG MIX 50-50 (insulin lispro), HUMILIN 70-30 (insulin), HUMILIN N (insulin), HUMULIN R (insulin) or GEMZAR (gemcitabine).


Find Patent Forward Citations

Loading…